DME Express Competitors and Similar CompaniesClear all

DME Express's competitors and similar companies include Guanhao Biotech, Paragon 28, Thimar and Dynasplint Systems.

	DME Express DME Express is a supplier of medical and nursing equipment.	Guanhao Biotech Guanhao Biotech (冠昊生物科技股份有限公司) is a company that researches, develops, produces, and sells regeneration medical materials and implanted devices.	Paragon 28 Paragon 28 is a medical device company focused on the foot and ankle orthopedic technologies.	Thimar Thimar is a distributor of healthcare products in the pharmaceutical, medical, and dental industries.	Dynasplint Systems Dynasplint Systems is a company that designs, manufactures, and sells dynamic splinting devices.
Founding Date	Founding Date 2006	Founding Date N/A	Founding Date 2010	Founding Date 1980	Founding Date 1981
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare distribution medical devices	Tags Healthcare distribution medical devices	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare distribution medical devices	Tags Healthcare distribution medical devices
Locations	Locations Port Allen, US HQ	Locations Guangzhou, CN HQ Beijing, CN Guangzhou, CN	Locations Englewood, US HQ Dublin, IE Ada, US	Locations US HQ Al Khobar, SA Jeddah, SA Riyadh, SA	Locations Severna Park, US HQ Vaughan, CA Hoensbroek, NL
Employees	Employees 1761% increase	Employees 535	Employees 57424% increase	Employees 215	Employees 3611% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 497.9 m	Valuation ($) 433.6 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥365.4m (FY, 2025)	Revenue (est.) $256.2m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥88.7m (FY, 2025)	Cost of goods $64.7m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥291.6m (FY, 2025)	Gross profit $191.5m (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ¥14.8m (FY, 2025)	Net income ($54.6m) (FY, 2024)	Net income N/A	Net income N/A